Prognosis
Will Bill Cassidy ask tough questions?
View in browser
Bloomberg

Prognosis is exclusively for Bloomberg.com subscribers. As a loyal reader, you’re receiving a complimentary trial. If you’d like to continue receiving Prognosis, and gain unlimited digital access to all of Bloomberg.com, we invite you to subscribe now at the special rate of $149 for your first year (usually $299).

Hi, it’s Cynthia and Steve. Robert F. Kennedy Jr. may be the one in the hot seat today as he prepares to defend his health record in front of the Senate Finance Committee. But there’s actually a different politician in the room who’s even more crucial to watch. More on that in a moment, but first ...

Today’s must-reads

  • Pfizer said Trump deserves a Nobel Prize for Operation Warp Speed. 
  • RFK Jr. moved to add more hand-picked vaccine advisory panel members. 
  • Americans don’t know whether they can get Covid shots. 

Face-off

Bill Cassidy has been torn between two loyalties: medicine and politics. On one hand, he’s a medical doctor who’s publicly extolled the virtues of vaccines. On the other, he’s a Republican senator up for reelection in the red state of Louisiana who faces political risks if he openly defies the Trump administration.

Cassidy, who’s head of the Senate Committee on Health, Education, Labor and Pensions, very publicly wrestled with approving Kennedy as Health and Human Services secretary at the beginning of the year. He said he extracted concessions from Kennedy on vaccines and staffing in exchange for his yes vote.

But Cassidy has struggled to gain ground in his role as a self-appointed Kennedy watchdog. Since taking office earlier this year, Kennedy has moved to undo parts of America’s vaccine infrastructure. He dismissed all the members of a key vaccine advisory committee, delaying immunization decisions on who gets shots and whether insurers cover them, then installed vaccine critics on that panel. Kennedy clashed with head of the Centers for Disease Control and Prevention, Susan Monarez, over immunizations and fired her just weeks after she’d been confirmed by the Senate for that role.

Meanwhile, misinformation about vaccines is running rampant — to a dangerous extent. A gunman opened fire at the CDC campus last month after outlining his frustrations with Covid vaccines. Kennedy, who was a leading voice in the anti-vaccine movement during the pandemic, wouldn’t blame the shooting on vaccine misinformation.

Kennedy uses the terminology of mainstream medicine, like returning the CDC to “gold standard science,” even as he makes policy moves more closely with those with anti-vaccination views. In the midst of a measles outbreak that killed two children in Texas, he posted both that vaccines are “the most effective way to prevent the spread of measles,” while also touting unconventional therapies like steroids and antibiotics.

The shifting rules and political rhetoric mean that doctors and patients don’t even know whether they can get Covid shots this season. 

All this leaves Cassidy in a bind. It’s clear Kennedy’s pushing forward with an agenda that will make it harder for people to get shots. 

So far, Cassidy hasn’t called for an investigation into Kennedy’s handling of the CDC director’s firing, which could unearth even more information about Kennedy’s anti-vaccine objectives. But on Tuesday, he shared his frustration with reporters.  

“This is about children's health,” Cassidy said. “This is about how we protect the children of the United States of America. And there’s allegations that their health is being endangered. Without presupposing anybody’s right or wrong, we’ve got to get to the bottom of it. And it’ll take radical transparency. My colleagues agree.”

While this might imply Cassidy will take a hard line with Kennedy at the hearing, when asked whether he still has confidence in the health secretary, Cassidy held back, saying he’s “reserving judgement.”

Today’s hearing should offer a window into what judgement Cassidy ultimately makes about Kennedy — and what steps Congress takes to wade into the now perpetually political conversation around vaccines. — Cynthia Koons and Steven T. Dennis

Note: Yesterday’s newsletter was corrected to give the full name of an organization arguing that psilocybin should be reclassified as a Schedule II drug by the US government.

What we’re reading

More than 16 million seniors aged 65 and older in the US live alone. The Wall Street Journal reports on who will take care of them. 

US media is wrestling with how to handle the health of the president, the AP reports

Can you poop outdoors without contaminating the environment? PBS News explains how to do it safely. 

Contact Prognosis

Health questions? Have a tip that we should investigate? Contact us at AskPrognosis@bloomberg.net.

Follow Us

Like getting this newsletter? There's more where that came from. Browse all our weekly and daily emails to get even more insights from your Bloomberg.com subscription.

Want to sponsor this newsletter? Get in touch here.

You received this message because you are subscribed to Bloomberg's Prognosis newsletter. If a friend forwarded you this message, sign up here to get it in your inbox.
Unsubscribe
Bloomberg.com
Contact Us
Bloomberg L.P.
731 Lexington Avenue,
New York, NY 10022
Ads Powered By Liveintent Ad Choices